Efficacy and effectiveness of tumour necrosis factor inhibitors in the treatment of rheumatoid arthritis in randomized controlled trials and routine clinical practice

Kalle J. Aaltonen, Suvi Ylikylä, Jaana Tuulikki Joensuu, Pia Isomäki, Laura Pirilä, Markku Kauppi, Tuomas Rannio, Kari Eklund, Marja Blom, Dan Nordstrom

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalRheumatology
Volume56
Issue number5
Pages (from-to)725-735
Number of pages11
ISSN1462-0324
DOIs
Publication statusPublished - May 2017
MoE publication typeA1 Journal article-refereed

Fields of Science

  • rheumatoid arthritis
  • anti-TNF
  • methotrexate
  • outcomes research
  • randomized controlled trials
  • RECEIVING CONCOMITANT METHOTREXATE
  • MODIFYING ANTIRHEUMATIC DRUGS
  • DOUBLE-BLIND
  • MONOCLONAL-ANTIBODY
  • CERTOLIZUMAB PEGOL
  • PHASE-III
  • EULAR RECOMMENDATIONS
  • PLUS METHOTREXATE
  • PARALLEL-GROUP
  • FACTOR-ALPHA
  • 3121 General medicine, internal medicine and other clinical medicine
  • 317 Pharmacy

Cite this